Newsletters
Regulatory Codification of Coverage-Medicare Advantage Plans
April 2023
The Center of Medicare and Medicaid Services (CMS) recently proposed regulation (Section 422.101) directed towards commercial insurance Medicare Advantage (MA) health plans.
Women’s Business Enterprise National Council (WBENC) Re-Certifies Rowinski Group as a Women Business Enterprise (WBE)
January 2023
The Women’s Business Enterprise is a national certification. It is relevant for companies (publicly traded, privately held and not-for-profit) and universities who use supplier diversity programs to award contracted services.
Public Comment for the CMS Proposed Medicare Payment rates for the Hospital Outpatient and Ambulatory Surgical Center
July 2022
In the proposed rule there are three notable provisions. First to increase payment rates by 2.7% for hospitals and ASCs meeting applicable quality reporting requirements for CY 2023, using the June 2020 cost report and CY 2021 data to set CY 2023 OPPS and ASC payment system rates.
FDA Designated Breakthrough Devices-Upcoming Proposal to Expedite Medicare Coverage
April 2022
It is important for companies to understand Medicare repleaded the MCIT in November 2021. The MCIT would have granted expedited Medicare coverage for up to four years for all US FDA-designated breakthrough devices once the device received or cleared market authorization.
Rowinski Group Awarded National Re-Certification as a Women’s Business Enterprise
February 2022
Rowinski Group LLC, a reimbursement consultancy for medical device, diagnostics, and digital therapeutics companies is proud to announce Rowinski Group was re-certified as a Women’s Business Enterprise. The Women’s Business Enterprise is a national certification. It is relevant for companies....
The University of California-San Francisco (UCSF) Rosenman Institute Program Funding Opportunity
March 2021
The UCSF Rosenman Institute provides startups with expertise and mentor-ship from stakeholders across the healthcare industry. The Institute is inviting (40) startups to pitch on May 4 or 5 to a panel of judges comprised of financial/strategic investors, subject matter experts, and clinicians....
Rowinski Group Awarded National Re-Certification by the Women’s Business Enterprise National Council
February 2021
Rowinski Group LLC, a reimbursement and healthcare payer data analytics consultancy for medical device, diagnostics, and digital health companies is proud to announce the firm was re-certified as a Women’s Business Enterprise (WBE).
Permanent Changes to Medicare Reimbursement for Clinicians
August 2020
We believe Medicare's Quality Payment Program may provide an opportunity to monetize your medical device, digital health technology, or diagnostic test in the absence of fee-for-service reimbursement. Medicare has set the standard for reimbursement based on healthcare providers delivering quality clinical care. This standard is under consideration by other U.S. health insurance payers.